Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at the Lebanese American University Medical Center- Rizk Hospital

NCT04631536 is registered in ClinicalTrials.gov with Lebanese American University Medical Center as lead sponsor.

NCT NCT04631536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04631536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at the Lebanese American University Medical Center- Rizk Hospital
Lead sponsor
Lebanese American University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
January 10, 2021
Completion date
July 1, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19